Amedisys Inc (AMED) Stock Price Today
Key Stats
- $3.32BMarket Cap
- -Volume
- HealthSector
- $100.9952W High
- $83.7852W Low
- 29 DaysTypical Hold Time
- $3.43BEnterprise Value
- -Div Yield
- -Trading Activity
Track Amedisys Inc (AMED) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Amedisys Inc has traded between a low of $83.78 and a high of $100.99, highlighting its annual price range. Buy and sell Amedisys Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Amedisys Inc
Amedisys Inc is a healthcare services company in the United States. The company brings healthcare to the home through the provision of home healthcare services, hospice services, high acuity care segment , and personal care services. The Home Health Segment provides skilled nurses, therapists, and aids to patients' homes throughout the United States, Hospice segment operates many centers designed to provide comfort and support for terminally ill patients, Personal Care Segment provides individuals with assistance in their daily living activities and High acuity care segment can deliver the essential elements of inpatient hospital, SNF care, and palliative care to patients in their homes. A majority of the company's revenue is derived from the Home Health segment.
Most Recent News
US Treasury says Operation Economic Outcast sanctions on Iran are a complete success, isolating Iran financially and industrially.
The US Treasury Department's Operation Economic Outcast, launched in August 2026, has successfully isolated Iran from the global financial system by targeting its key industries including digital assets, gold, aviation, and shipping. The campaign has...
Gildan Activewear faces class action over alleged misleading business info causing 18.7% stock drop
Rosen Law Firm is investigating a class action lawsuit against Gildan Activewear Inc. after allegations that the company issued misleading business information. This followed a short seller report claiming Gildan's organic growth was negative despite...
Closed-end funds drop in September amid rising rates, with some funds raising payouts and others doing reverse splits.
In September, closed-end funds (CEFs) broadly declined due to rising long-term interest rates and wider discounts, making current valuations attractive for investors. Notable fund actions include Loan/CLO Equity CEF XFLT launching a tender offer at a...
People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.